Family Medicine · Dewitt, AR
NPI
1295839397
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
705 W 16th St
Dewitt, AR, 72042
Phone (870) 946-1326
Groups this clinician bills Medicare through
Medicare paid, 2024
$179K
24,664 services
Medicare patients, 2024
558
Average age 75
Drug cost, 2024
$856K
19,558 prescriptions
Company payments, 2025
$20.3
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stanley W Burleson was code J1010 (injection, methylprednisolone acetate, 1 mg), 19,542 times for 178 patients. In total Stanley W Burleson billed 24,664 services in 69 codes, and Medicare paid $179K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 19,542 | 178 | $0.10 | $1,904 |
| 99213 Office E&M - Established | Office | 1,757 | 495 | $52.99 | $93K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 675 | 82 | $0.08 | $54.66 |
| 96372 Injection Administration | Office | 528 | 255 | $8.17 | $4,312 |
| 36415 Venipuncture Blood Collection | Office | 457 | 340 | $8.65 | $3,953 |
| 99214 Office E&M - Established | Office | 206 | 147 | $88.13 | $18K |
| 99231 Hospital E&M - Subsequent | Facility | 169 | 44 | $33.98 | $5,742 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 159 | 159 | $116.83 | $19K |
| 99308 SNF E&M | Office | 150 | 29 | $48.83 | $7,325 |
| 99221 Hospital E&M - Initial | Facility | 114 | 77 | $54.21 | $6,180 |
| 99238 Hospital Discharge Management | Facility | 112 | 75 | $54.69 | $6,125 |
| 85610 Clinical Chemistry | Office | 98 | 15 | $4.20 | $412 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 94 | 77 | $4.17 | $392 |
| 97032 PT Treatment | Office | 92 | 50 | $7.77 | $715 |
| 93793 Care Management/Coordination | Office | 56 | 12 | $6.57 | $368 |
By year: 2022 $247K for 5,226 services; 2023 $204K for 4,978 services; 2024 $179K for 24,664 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 457 | 340 | $8.65 | $3,953 |
| 85610 Clinical Chemistry | 98 | 15 | $4.20 | $412 |
| 81000 Clinical Chemistry | 16 | 15 | $3.94 | $63.04 |
Medicare prescription drug claims, 2024
In 2024, the drug Stanley W Burleson prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,019 prescriptions and refills. In total Stanley W Burleson wrote 19,558 Medicare prescriptions that cost $856K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,019 | 1,319 | 126 | $6,426 |
| Losartan Potassium Generic | 598 | 734 | 84 | $2,118 |
| Amlodipine Besylate Generic | 596 | 794 | 88 | $1,118 |
| Atorvastatin Calcium Generic | 586 | 729 | 81 | $2,259 |
| Pantoprazole Sodium Generic | 579 | 673 | 80 | $2,742 |
| Lisinopril Generic | 501 | 636 | 69 | $1,376 |
| Gabapentin Generic | 452 | 505 | 70 | $4,788 |
| Metoprolol Tartrate Generic | 452 | 514 | 66 | $1,262 |
| Citalopram Hbr Citalopram Hydrobromide | 424 | 511 | 54 | $1,357 |
| Simvastatin Generic | 410 | 502 | 53 | $1,345 |
| Potassium Chloride Generic | 408 | 457 | 66 | $5,740 |
| Tamsulosin Hcl Generic | 400 | 538 | 63 | $4,326 |
| Omeprazole Generic | 386 | 479 | 55 | $2,371 |
| Allopurinol Generic | 350 | 424 | 46 | $1,883 |
| Clopidogrel Clopidogrel Bisulfate | 335 | 380 | 43 | $1,558 |
Brand drugs: 2,205 claims; generic drugs: 17,196 claims; opioid claims: 489.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stanley W Burleson $20.3 ($20.3 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $20.3.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $20.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.